Cite
MLA Citation
Richard S. Finn et al.. “Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up.” Oncologist, vol. 26, 2021, pp. e749–e755. http://access.bl.uk/ark:/81055/vdc_100129576478.0x000039